ATLASAdial Pharmaceuticals (ADIL) earnings date: Nov 12, 2026
Adial Pharmaceuticals (ADIL) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ADIL
| Last price | $3.81 (-21.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±9.3% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Adial Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Adial Pharmaceuticals reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Adial Pharmaceuticals. You can switch it off at any time.
Alert me before ADIL reportsFree to start. Creating an account takes under a minute.
Notify me when Adial Pharmaceuticals reports
Track ADIL free Add Adial Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
ADIL earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 14, 2026 · Miss |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -3.9% |
| Average move around a report | ±5.3% (last 4) |
| Sector | Healthcare · Biotechnology |
Adial Pharmaceuticals earnings history: last 4 reports
Adial Pharmaceuticals last reported on Aug 14, 2026: EPS of -$1.29 against an estimate of -$0.91 (-41.8% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$0.91 | -$1.29 | -41.8% | Miss | +13.7% |
| Jul 16, 2026 | $1.10 | $1.17 | +6.4% | Beat | +2.9% |
| Jun 25, 2026 | -$0.14 | -$0.16 | -14.3% | Miss | +3.2% |
| May 8, 2026 | -$2.25 | -$1.48 | +34.2% | Beat | +1.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ADIL
See the fair value, the probability range and the earnings history of Adial Pharmaceuticals on its ATLAS page.
Adial Pharmaceuticals (ADIL) stock analysisPlans from €3.99 a month.
Adial Pharmaceuticals earnings: frequently asked questions
When does Adial Pharmaceuticals (ADIL) report earnings?
Adial Pharmaceuticals is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does ADIL beat earnings estimates?
Of its last 4 reports with a recorded result, Adial Pharmaceuticals beat the EPS estimate 2 times; the average surprise was -3.9%. Past results do not predict the next one.
How much does ADIL move around earnings?
Over its last 4 reports the stock moved an average of 5.3% (absolute, from the close before the report day to the close after it), and finished higher 4 of 4 times.
Did Adial Pharmaceuticals beat earnings estimates last quarter?
Adial Pharmaceuticals last reported on Aug 14, 2026: EPS of -$1.29 against an estimate of -$0.91 (-41.8% surprise), a miss.
How much does ADIL usually move in a day?
On a normal trading day the ATLAS model puts ADIL’s one-day range at about ±9.3%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer